Biotech Acquisition Company
545 West 25th Street, 20th Floor
New York, NY 10001
May 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Dillon Hagius | |
Laura Crotty | ||
Ibolya Ignat | ||
Kevin Vaughn |
Re: | Biotech Acquisition Company File No. 333-263577 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biotech Acquisition Company hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4 p.m. ET on May 9, 2022, or as soon as practicable thereafter.
Very truly yours, | |
/s/ Albert F. Hummel | |
Albert F. Hummel | |
Chief Investment Officer and Director |
cc: | Ellenoff Grossman & Schole LLP |